A Study of Radiation Therapy in Combination With Cemiplimab Compared to Chemotherapy in Combination With Cemiplimab in People With Non-Small Cell Lung Cancer (NSCLC)

Full Title

Multicenter Randomized Phase II Trial of Neoadjuvant Radioimmunotherapy Versus Chemoimmunotherapy in Patients with Clinical Stages IB-III (N2) Non-small Cell Lung Cancer

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. David Jones’ office at 212-639-6428.

Protocol

25-370

Phase

Phase II (phase 2)

Investigator

David R. Jones

Co-Investigators

Jamie E. Chaft
Narek Shaverdian

Diseases

Lung Cancer › Lung Cancer, Non-Small Cell

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT06623656

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description